ENDRA Life Sciences(NDRA) - 2025 Q2 - Quarterly Results

Financial Reporting - The preliminary estimated financial results for the fiscal quarter ended June 30, 2025, are included in the Prospectus[4] Public Offering - ENDRA Life Sciences Inc. filed a Registration Statement on Form S-1 for a public offering of common stock and warrants on July 9, 2025[4] Company Classification - The Company is not classified as an emerging growth company under the Securities Act[4]